Nitto Avecia
Jennifer Monahan is a seasoned professional in the pharmaceutical and biotech industries, currently serving as an Associate Principal Scientist at Nitto Avecia since April 2016. With a progressive career that began as a Quality Control Analyst II at PCI Synthesis in 2011, Jennifer has held various roles including Bioanalytical Chemist at Toxikon Corporation, and multiple positions in analytical development at Pharmalucence. Academic credentials include a Master's degree in Medicinal Chemistry from the Massachusetts College of Pharmacy and Health Sciences and a Bachelor's degree in Biochemistry from Merrimack College.
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.